Pharmaceutical Liquid Composition Stabilized by Water-Soluble Additives

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing liquid compositions containing N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide or its salts suffer from insufficient stability, particularly when prepared with water, which affects their efficacy as anti-inflammatory and anti-pancreatitis agents.

Innovation Solution

Incorporating a water-soluble additive, such as a surfactant, cyclodextrin, or antioxidant, into the liquid composition enhances the stability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide or its salts, maintaining a residual rate of 90% or more after storage at 40°C for 2 weeks and minimizing decomposition products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a liquid composition containing water is prepared using commonly used methods, then the composition can be easily manufactured, but the stability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide or a salt thereof is insufficient

Engineering Contradiction:
Improvestability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamideVSAvoidease of preparation
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

A water-soluble additive is introduced as an intermediary substance to mediate between the active ingredient and water, improving the stability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide in the liquid composition without complicating the manufacturing process

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The composition parameters are optimized by controlling the pH value within 3-9 and the concentration of the water-soluble additive at 0.01-10% by mass, which improves the stability of the active ingredient while maintaining ease of manufacture through straightforward parameter specification

Inventive Principle:
Principle #35Parameter changes

2Duration of action of moving object

If the liquid composition is stored at high temperature (40°C), then the therapeutic effect can be maintained, but the compound decomposes and the residual rate decreases

Engineering Contradiction:
Improveduration of effectivenessVSAvoidcompositional stability
Core Design Contradiction:
Duration of action of moving objectVSStability of the object's composition

Solution Approach 1:

A water-soluble additive is incorporated into the composition in advance to cushion against thermal decomposition, enabling the compound to maintain stability even when stored at elevated temperatures of 40°C, thus preserving both duration of action and compositional stability

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

3Reliability

If no water-soluble additive is added, then the composition is simpler, but the compound decomposes and precipitation occurs

Engineering Contradiction:
Improvestability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamideVSAvoidcomplexity of composition
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

A water-soluble additive serves as a simple intermediary component that prevents decomposition and precipitation of the active ingredient, achieving improved reliability without significantly increasing composition complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

By optimizing the pH value to 3-9 and the additive concentration to 0.01-10% by mass, the composition achieves enhanced stability with minimal complexity, as these parameter ranges cover most conventional pharmaceutical formulations

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves improved chemical and physical stability, ensuring the compound remains effective for a longer duration without precipitation, thereby enhancing its practical use and therapeutic efficacy.

Implementation Method 1

Incorporating a water-soluble additive, such as a surfactant, cyclodextrin, or antioxidant, into the liquid composition enhances the stability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide or its salts

Methodology Applied
Scientific EffectStabilization:

Implementation Method 2

a water-soluble additive, such as a surfactant, cyclodextrin, or antioxidant

Methodology Applied
Scientific EffectOxidation prevention: Oxidation

Implementation Method 3

the water-soluble additive is at least one selected from the group consisting of a surfactant, cyclodextrin or a cyclodextrin derivative, and an antioxidant

Methodology Applied
Scientific EffectInclusion complexation:

Data Source

PatentUS12396987B2Pharmaceutical composition with excellent storage stability
Publication Date: 2025.08.26 ISHIHARA SANGYO KAISHA LTD
  • US12396987B2 patent drawing
  • US12396987B2 patent drawing
  • US12396987B2 patent drawing

AI summary

The present invention provides a composition which effectively enhances the stability of N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide or a salt thereof in a liquid composition. More specifically, the present invention provides a liquid composition comprising N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide or a salt thereof, a water-soluble additive and water.